标题
Gene therapy for glycogen storage diseases
作者
关键词
-
出版物
HUMAN MOLECULAR GENETICS
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2019-06-08
DOI
10.1093/hmg/ddz133
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Intravenous Injection of an AAV-PHP.B Vector Encoding Human Acid α-Glucosidase Rescues Both Muscle and CNS Defects in Murine Pompe Disease
- (2019) Jeong-A Lim et al. Molecular Therapy-Methods & Clinical Development
- Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
- (2019) Hye-Ri Kang et al. Molecular Therapy-Methods & Clinical Development
- Systemic delivery of AAVB1-GAA clears glycogen and prolongs survival in a mouse model of Pompe disease
- (2018) Allison May Keeler et al. HUMAN GENE THERAPY
- Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia
- (2018) Young Mok Lee et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy
- (2018) Paul T. McIntosh et al. MOLECULAR GENETICS AND METABOLISM
- Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression
- (2018) Patrice Vidal et al. MOLECULAR THERAPY
- Correction of Biochemical Abnormalities and Improved Muscle Function in a Phase I/II Clinical Trial of Clenbuterol in Pompe Disease
- (2018) Dwight D. Koeberl et al. MOLECULAR THERAPY
- Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases
- (2018) Natalie Pursell et al. MOLECULAR THERAPY
- Letter to the Editors: Concerning “Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia” by Lee et al.
- (2018) Elizabeth D. Brooks et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy
- (2018) Elizabeth D. Brooks et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors
- (2017) Marianna Hösel et al. HEPATOLOGY
- Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene Therapy
- (2017) Haiqing Yi et al. HUMAN GENE THERAPY
- Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy
- (2017) Goo-Young Kim et al. HUMAN MOLECULAR GENETICS
- Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T > G “late-onset” GAA variant
- (2017) Mugdha V. Rairikar et al. MOLECULAR GENETICS AND METABOLISM
- Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors
- (2017) Goo-Young Kim et al. MOLECULAR GENETICS AND METABOLISM
- The emerging phenotype of late-onset Pompe disease: A systematic literature review
- (2017) Justin Chan et al. MOLECULAR GENETICS AND METABOLISM
- Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase
- (2017) Francesco Puzzo et al. Science Translational Medicine
- Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction
- (2017) Sang-oh Han et al. Molecular Therapy-Methods & Clinical Development
- Immunomodulatory, liver depot gene therapy for Pompe disease
- (2017) J.E. Bond et al. CELLULAR IMMUNOLOGY
- Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease
- (2016) Phillip A. Doerfler et al. HUMAN GENE THERAPY
- Danon disease – dysregulation of autophagy in a multisystem disorder with cardiomyopathy
- (2016) Teisha J. Rowland et al. JOURNAL OF CELL SCIENCE
- Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome
- (2016) Christiaan P. Sentner et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Exercise and Preexercise Nutrition as Treatment for McArdle Disease
- (2016) GISELA NOGALES-GADEA et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA
- (2016) Dustin J Landau et al. MOLECULAR THERAPY
- Skeletal and cardiac muscle involvement in children with glycogen storage disease type III
- (2015) Engy A. Mogahed et al. EUROPEAN JOURNAL OF PEDIATRICS
- McArdle Disease: Update of Reported Mutations and Polymorphisms in thePYGMGene
- (2015) Gisela Nogales-Gadea et al. HUMAN MUTATION
- Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics
- (2014) Priya S. Kishnani et al. GENETICS IN MEDICINE
- Ocular and Histologic Findings in a Series of Children With Infantile Pompe Disease Treated With Enzyme Replacement Therapy
- (2014) S. Grace Prakalapakorn et al. JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS
- Assessment of toxicity and biodistribution of recombinant AAV8 vector–mediated immunomodulatory gene therapy in mice with Pompe disease
- (2014) Gensheng Wang et al. Molecular Therapy-Methods & Clinical Development
- The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia
- (2013) Young Mok Lee et al. MOLECULAR GENETICS AND METABOLISM
- Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease
- (2012) Songtao Li et al. FASEB JOURNAL
- The emerging phenotype of long-term survivors with infantile Pompe disease
- (2012) Sean N. Prater et al. GENETICS IN MEDICINE
- Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy
- (2012) Young Mok Lee et al. HEPATOLOGY
- Immunodominant Liver-Specific Expression Suppresses Transgene-Directed Immune Responses in Murine Pompe Disease
- (2012) Ping Zhang et al. HUMAN GENE THERAPY
- Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry
- (2012) Alejandro Lucia et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The impact of antibodies in late-onset Pompe disease: A case series and literature review
- (2012) Trusha T. Patel et al. MOLECULAR GENETICS AND METABOLISM
- Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy
- (2012) B. J. Ebbink et al. NEUROLOGY
- Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle
- (2011) Dwight D. Koeberl et al. MOLECULAR GENETICS AND METABOLISM
- Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases
- (2011) Pablo Perez-Pinera et al. NUCLEIC ACIDS RESEARCH
- Glycogen Storage Diseases: A Brief Review and Update on Clinical Features, Genetic Abnormalities, Pathologic Features, and Treatment
- (2011) John Hicks et al. ULTRASTRUCTURAL PATHOLOGY
- Glycogen Storage Disease Type III diagnosis and management guidelines
- (2010) Priya S Kishnani et al. GENETICS IN MEDICINE
- Adeno-Associated Virus-Mediated Correction of a Canine Model of Glycogen Storage Disease Type Ia
- (2010) David A. Weinstein et al. HUMAN GENE THERAPY
- Complete Normalization of Hepatic G6PC Deficiency in Murine Glycogen Storage Disease Type Ia Using Gene Therapy
- (2010) Wai Han Yiu et al. MOLECULAR THERAPY
- Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants
- (2009) Priya S. Kishnani et al. MOLECULAR GENETICS AND METABOLISM
- Immunomodulatory Gene Therapy Prevents Antibody Formation and Lethal Hypersensitivity Reactions in Murine Pompe Disease
- (2009) Baodong Sun et al. MOLECULAR THERAPY
- Ability of Adeno-Associated Virus Serotype 8-Mediated Hepatic Expression of Acid α-Glucosidase to Correct the Biochemical and Motor Function Deficits of Presymptomatic and Symptomatic Pompe Mice
- (2008) Robin J. Ziegler et al. HUMAN GENE THERAPY
- Gene Delivery to the Juvenile Mouse Liver Using AAV2/8 Vectors
- (2008) Sharon C Cunningham et al. MOLECULAR THERAPY
- AAV Vector-mediated Reversal of Hypoglycemia in Canine and Murine Glycogen Storage Disease Type Ia
- (2008) Dwight D Koeberl et al. MOLECULAR THERAPY
- Correction of Multiple Striated Muscles in Murine Pompe Disease Through Adeno-associated Virus–mediated Gene Therapy
- (2008) Baodong Sun et al. MOLECULAR THERAPY
- Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle’s disease: Expression and re-expression of glycogen phosphorylase
- (2008) J.McC. Howell et al. NEUROMUSCULAR DISORDERS
- McArdle disease: what do neurologists need to know?
- (2008) Alejandro Lucia et al. Nature clinical practice. Neurology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started